Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Armata Pharmaceuticals, Inc (ARMP)  
$0.32 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 24,940,000
Market Cap: 7.93(M)
Last Volume: 4,742 Avg Vol: 4,729
52 Week Range: $0.3179 - $0.3179
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Co. is developing and advancing its primary clinical phage candidate for Pseudomonas aeruginosa. Co. is also developing a phage product candidate for Staphylococcus aureus for the treatment of S. aureus bacteremia. In addition, Co. has phage development efforts underway to target other indications including non-cystic fibrosis bronchiectasis, prosthetic joint infections and hospitalized pneumonia.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 37
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Martin Steven Robert Chief Financial Officer   •       –      –    2016-12-09 4 A $0.39 $1,466 D/D 3,760 3,760     -
   Salka Michael Scott Chief Executive Officer   •       •      –    2016-12-09 4 A $0.39 $2,730 D/D 7,000 11,200     -
   Cook Jeremy Curnock Director   –       •      –    2016-11-22 4 B $7.40 $345,328 I/I 46,666 118,513 2.1     -
   Intrexon Corp 10% Owner   –       –       •   2016-11-12 4 A $0.00 $0 I/I 428,571 828,571     -
   Cook Jeremy Curnock Director   –       •      –    2016-06-21 4 B $0.00 $0 I/I 15,057 71,847 2.02     -
   Cook Jeremy Curnock Director   –       •      –    2016-04-08 4 B $0.00 $0 I/I 171,298 567,903 2.02     -
   Cook Jeremy Curnock Director   –       •      –    2016-04-08 4 A $0.00 $0 I/I 208,150 396,605     -
   Drapeau Louis Director   –       •      –    2015-10-06 4 B $4.39 $43,900 D/D 10,000 10,000 2.39     -
   Johnson Wendy S. Interim Chief Operating Office   •       •      –    2015-10-05 4 B $4.43 $4,427 D/D 1,000 1,000 2.73     -
   Salka Michael Scott Chief Executive Officer   •       •      –    2015-10-05 4 B $4.75 $19,950 D/D 4,200 4,200 2.81     -
   Cook Jeremy Curnock Director   –       •      –    2015-03-16 4 B $8.25 $564,754 I/I 68,455 188,455 2.1     -
   Intrexon Corp 10% Owner   –       –       •   2015-03-16 4 B $0.17 $2,300,000 I/I 13,939,392 37,939,392 1.5     -

  37 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed